Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12608000372381Phase 4Active, not recruiting
Phase 4, open-label trial of thalidomide, pentoxifylline, colchicine and dapsone in aphthosis (RAS) (4 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Reduction of recurrent aphthous stomatitis bouts. Started Feb 2004; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12608000372381.